Pharma Mar (OTCMKTS:PHMMF – Get Free Report)’s share price hit a new 52-week high on Friday . The stock traded as high as $110.40 and last traded at $110.40, with a volume of 400 shares. The stock had previously closed at $102.25.
Pharma Mar Stock Up 8.0%
The company has a quick ratio of 2.33, a current ratio of 2.97 and a debt-to-equity ratio of 0.20. The stock’s fifty day simple moving average is $97.09 and its 200-day simple moving average is $93.88.
About Pharma Mar
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
Further Reading
- Five stocks we like better than Pharma Mar
- 5 Top Rated Dividend Stocks to Consider
- Why the Precious Metal Nobody Talks About Could Be Your Best Bet
- How to Most Effectively Use the MarketBeat Earnings Screener
- Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
Receive News & Ratings for Pharma Mar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma Mar and related companies with MarketBeat.com's FREE daily email newsletter.
